| Palbociclib | Approved Investigational | TUBB4B | 10383 |
downregulated | palbociclib results in decreased expression of TUBB4B mRNA | 9q34.3 | |
| Palbociclib | Approved Investigational | TYMS | 7298 |
downregulated | palbociclib results in decreased expression of TYMS mRNA | 18p11.32 | |
| Palbociclib | Approved Investigational | UBE2C | 11065 |
downregulated | palbociclib results in decreased expression of UBE2C mRNA | 20q13.12 | |
| Palbociclib | Approved Investigational | UBE2T | 29089 |
downregulated | palbociclib results in decreased expression of UBE2T mRNA | 1q32.1 | |
| Palbociclib | Approved Investigational | UHRF1 | 29128 |
downregulated | palbociclib results in decreased expression of UHRF1 mRNA | 19p13.3 | |
| Palbociclib | Approved Investigational | ZWINT | 11130 |
downregulated | palbociclib results in decreased expression of ZWINT mRNA | 10q21-q22 | |
| Palmitic Acid | Approved Investigational | ABCG1 | 9619 |
upregulated | Palmitic Acid results in increased expression of ABCG1 mRNA | 21q22.3 | |
| Palmitic Acid | Approved Investigational | CCL3 | 6348 |
upregulated | Palmitic Acid results in increased expression of CCL3 mRNA | 17q12 | |
| Palmitic Acid | Approved Investigational | CPT1A | 1374 |
upregulated | Palmitic Acid results in increased expression of CPT1A mRNA | 11q13.3 | |
| Palmitic Acid | Approved Investigational | CXCL8 | 3576 |
upregulated | Palmitic Acid results in increased expression of CXCL8 mRNA | 4q13.3 | |
| Palmitic Acid | Approved Investigational | EDN1 | 1906 |
upregulated | Palmitic Acid results in increased expression of EDN1 mRNA | 6p24.1 | |
| Palmitic Acid | Approved Investigational | GPX1 | 2876 |
downregulated | Palmitic Acid results in decreased expression of GPX1 mRNA | 3p21.31 | |
| Palmitic Acid | Approved Investigational | HAL | 3034 |
upregulated | Palmitic Acid results in increased expression of HAL mRNA | 12q23.1 | |
| Palmitic Acid | Approved Investigational | HAMP | 57817 |
upregulated | Palmitic Acid results in increased expression of HAMP mRNA | 19q13.12 | |
| Palmitic Acid | Approved Investigational | IGF2 | 3481 |
upregulated | Palmitic Acid results in increased expression of IGF2 mRNA | 11p15.5 | |
| Palmitic Acid | Approved Investigational | MT1E | 4493 |
downregulated | Palmitic Acid results in decreased expression of MT1E mRNA | 16q13 | |
| Palmitic Acid | Approved Investigational | MT1F | 4494 |
downregulated | Palmitic Acid results in decreased expression of MT1F mRNA | 16q13 | |
| Palmitic Acid | Approved Investigational | MT1H | 4496 |
downregulated | Palmitic Acid results in decreased expression of MT1H mRNA | 16q13 | |
| Palmitic Acid | Approved Investigational | MT1X | 4501 |
downregulated | Palmitic Acid results in decreased expression of MT1X mRNA | 16q13 | |
| Palmitic Acid | Approved Investigational | MT2A | 4502 |
downregulated | Palmitic Acid results in decreased expression of MT2A mRNA | 16q13 | |
| Palmitic Acid | Approved Investigational | NOS2 | 4843 |
upregulated | Palmitic Acid results in increased expression of NOS2 mRNA | 17q11.2 | |
| Palmitic Acid | Approved Investigational | PDX1 | 3651 |
downregulated | Palmitic Acid results in decreased expression of PDX1 mRNA | 13q12.2 | |
| Palmitic Acid | Approved Investigational | PPARGC1A | 10891 |
upregulated | Palmitic Acid results in increased expression of PPARGC1A mRNA | 4p15.2 | |
| Palmitic Acid | Approved Investigational | PSMC3IP | 29893 |
upregulated | Palmitic Acid results in increased expression of PSMC3IP mRNA | 17q21.2 | |
| Palmitic Acid | Approved Investigational | SELE | 6401 |
upregulated | Palmitic Acid results in increased expression of SELE mRNA | 1q24.2 | |